UCB sells surface specialties to cytec

摘要

Pharmaceutical and Specialty Chemical company,UCB announced on 1st october,that it has signed an agreement to sell its Surface Specialties business to Cytec Industries Inc.for a total amount of implied 1.5 billion of which implied by 1.3 billion in cash and implied by 0.2 billion in shares of Cytec (approximately 12% of the capital).